NasdaqGS - Nasdaq Real Time Price
USD
Revolution Medicines, Inc. (RVMD)
189.13
-1.14
(-0.60%)
As of 1:27:01 PM EDT. Market Open.
Trade RVMD on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutRevolution Medicines is transitioning from a clinical-stage biotechnology company into a commercial oncology business after U.S. Food and Drug Administration approval of RASONQUE (daraxonrasib) for previously treated metastatic pancreatic cancer. Recent data support the drug’s survival benefit, while investors are weighing its commercial opportunity against high valuation, safety considerations, and execution risks across the broader pipeline.
